Becton, Dickinson and Company (0R19.L)
USD 200.29
(-3.61%)
USD 200.29
(-3.61%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 14.73 Billion USD | 6.14% |
| 2022 | 13.88 Billion USD | -18.84% |
| 2021 | 17.11 Billion USD | -0.66% |
| 2020 | 17.22 Billion USD | -4.74% |
| 2019 | 18.08 Billion USD | -4.3% |
| 2018 | 18.89 Billion USD | 1.22% |
| 2017 | 18.66 Billion USD | 76.94% |
| 2016 | 10.55 Billion USD | -7.21% |
| 2015 | 11.37 Billion USD | 201.75% |
| 2014 | 3.76 Billion USD | 0.13% |
| 2013 | 3.76 Billion USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 14.09 Billion USD | -4.37% |
| 2024 Q3 | 18.13 Billion USD | 13.35% |
| 2024 Q2 | 15.99 Billion USD | 13.49% |
| 2023 Q1 | 14.26 Billion USD | 2.75% |
| 2023 Q4 | 14.73 Billion USD | -1.26% |
| 2023 FY | 14.73 Billion USD | 6.14% |
| 2023 Q3 | 14.92 Billion USD | -6.77% |
| 2023 Q2 | 16.01 Billion USD | 12.21% |
| 2022 FY | 13.88 Billion USD | -18.84% |
| 2022 Q3 | 14.68 Billion USD | -16.5% |
| 2022 Q4 | 13.88 Billion USD | -5.43% |
| 2022 Q2 | 17.58 Billion USD | 7.48% |
| 2022 Q1 | 16.36 Billion USD | -4.38% |
| 2021 FY | 17.11 Billion USD | -0.66% |
| 2021 Q3 | 15.7 Billion USD | -11.39% |
| 2021 Q1 | 16.08 Billion USD | -8.42% |
| 2021 Q2 | 17.71 Billion USD | 10.17% |
| 2021 Q4 | 17.11 Billion USD | 8.98% |
| 2020 FY | 17.22 Billion USD | -4.74% |
| 2020 Q4 | 17.56 Billion USD | 0.75% |
| 2020 Q2 | 17.15 Billion USD | -0.78% |
| 2020 Q3 | 17.42 Billion USD | 1.6% |
| 2020 Q1 | 17.28 Billion USD | -4.38% |
| 2019 FY | 18.08 Billion USD | -4.3% |
| 2019 Q4 | 18.08 Billion USD | 0.36% |
| 2019 Q2 | 17.55 Billion USD | -1.46% |
| 2019 Q3 | 18.01 Billion USD | 2.62% |
| 2019 Q1 | 17.81 Billion USD | -5.7% |
| 2018 FY | 18.89 Billion USD | 1.22% |
| 2018 Q4 | 18.89 Billion USD | -7.15% |
| 2018 Q3 | 20.35 Billion USD | -9.91% |
| 2018 Q2 | 22.58 Billion USD | 2.24% |
| 2018 Q1 | 22.09 Billion USD | 18.36% |
| 2017 Q1 | 9.04 Billion USD | -14.28% |
| 2017 Q2 | 9.08 Billion USD | 0.43% |
| 2017 Q3 | 18.56 Billion USD | 104.39% |
| 2017 Q4 | 18.66 Billion USD | 0.56% |
| 2017 FY | 18.66 Billion USD | 76.94% |
| 2016 Q1 | 10.85 Billion USD | -4.5% |
| 2016 FY | 10.55 Billion USD | -7.21% |
| 2016 Q4 | 10.55 Billion USD | -0.1% |
| 2016 Q3 | 10.56 Billion USD | -2.79% |
| 2016 Q2 | 10.86 Billion USD | 0.06% |
| 2015 Q2 | 12.12 Billion USD | 22.01% |
| 2015 Q1 | 9.94 Billion USD | 163.8% |
| 2015 Q3 | 11.36 Billion USD | -6.27% |
| 2015 Q4 | 11.37 Billion USD | 0.03% |
| 2015 FY | 11.37 Billion USD | 201.75% |
| 2014 Q1 | 3.76 Billion USD | 0.03% |
| 2014 FY | 3.76 Billion USD | 0.13% |
| 2014 Q2 | 3.76 Billion USD | 0.0% |
| 2014 Q3 | 3.76 Billion USD | 0.11% |
| 2014 Q4 | 3.76 Billion USD | 0.0% |
| 2013 Q2 | 3.76 Billion USD | 0.01% |
| 2013 Q3 | 3.76 Billion USD | 0.01% |
| 2013 Q4 | 3.76 Billion USD | 0.01% |
| 2013 Q1 | 3.76 Billion USD | 0.0% |
| 2013 FY | 3.76 Billion USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Phreesia, Inc. | 2.04 Million USD | -719177.696% |
| Accuray Incorporated | 164.4 Million USD | -8864.72% |
| Align Technology, Inc. | 96.96 Million USD | -15098.828% |
| Elevance Health Inc. | 23.24 Billion USD | 36.6% |
| AxoGen, Inc. | 46.6 Million USD | -31524.574% |
| Boston Scientific Corporation | 8.56 Billion USD | -72.052% |
| CVS Health Corporation | 74.67 Billion USD | 80.263% |
| Cardinal Health, Inc. | 4.58 Billion USD | -221.58% |
| Centene Corporation | 17.69 Billion USD | 16.73% |
| DaVita Inc. | 8.05 Billion USD | -83.052% |
| HCA Healthcare, Inc. | 36.62 Billion USD | 59.763% |
| Hologic, Inc. | 2.49 Billion USD | -490.205% |
| Humana Inc. | 10.21 Billion USD | -44.306% |
| IDEXX Laboratories, Inc. | 622.88 Million USD | -2266.094% |
| Laboratory Corporation of America Holdings | 4.05 Billion USD | -263.479% |
| Masimo Corporation | 871.7 Million USD | -1590.719% |
| McKesson Corporation | 5.45 Billion USD | -170.372% |
| Patterson Companies, Inc. | 328.91 Million USD | -4380.847% |
| Quest Diagnostics Incorporated | 4.41 Billion USD | -234.195% |
| ResMed Inc. | 697.31 Million USD | -2013.542% |
| Henry Schein, Inc. | 1.93 Billion USD | -662.442% |
| Teladoc Health, Inc. | 1.58 Billion USD | -831.885% |
| Universal Health Services, Inc. | 4.71 Billion USD | -212.501% |
| Veeva Systems Inc. | 46.44 Million USD | -31634.889% |
| Baxter International Inc. | 11.06 Billion USD | -33.207% |
| Intuitive Surgical, Inc. | -82.1 Million USD | 18051.279% |
| Danaher Corporation | 17.66 Billion USD | 16.551% |
| Stryker Corporation | 10.9 Billion USD | -35.199% |
| Medtronic plc | 23.87 Billion USD | 38.275% |